Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evident designs and manufactures advanced life science microscopy solutions for research, clinical diagnostics/pathology/cytology, education, and industrial applications. The company was formerly the Scientific Solutions division of Olympus Corporation before becoming an independent entity in 2023. Its products include high-performance microscopes (brightfield/darkfield/fluorescence/confocal), digital pathology systems with AI-driven analysis capabilities, cameras for scientific imaging, as well as industrial measurement tools such as XRF analyzers and borescopes. Their technologies are widely used in academic research centers—including cancer biology labs—clinical labs for diagnostics support via digital pathology workflows—and across diverse industries requiring precision inspection or quality control. They do not develop drugs or biologics but enable discovery through their instrumentation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evident.